Recall due to exceeding the specification for related substances

Central contact points in each federal state survey needs and coordinate distribution

Recall due to colourless, instead of milky white emulsion

Recall due to increased reports of ring breakage

Recall due to particles affecting batches 8234, 8235 und 8236

Recall due to reduced active ingredient content

The all-clear can be given, because samples of the active substance noscapine from manufacturer and affected pharmacies have been examined in the meantime.

Due to recent incidents with extemporaneously compounded products prepared noscapine cough syrup, it is recommended not to use extemporaneously compounded products noscapine cough syrup or suppositories from now on.

Recall due to suspension of the marketing authorization

Marketing authorisation holders of homeopathic human medicinal products are informed that from 01.01.2020 [i.e. from the Data Lock Point: 30.09.2019] no further PSUR submissions are necessary, unless they are ordered by the BASG on a case-by-case basis.